[Pharmacogenetics].
D001463:Barbiturates / Q000009:adverse effects*; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D010597:Pharmacogenetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D011115:Polyneuropathies / Q000139:chemically induced* / Q000235:genetics; D011164:Porphyrias / Q000139:chemically induced* / Q000235:genetics; D011319:Primaquine / Q000009:adverse effects*; D012641:Selection, Genetic; D013390:Succinylcholine / Q000009:adverse effects*
D001463:Barbiturates; D013390:Succinylcholine; D011319:Primaquine; D007538:Isoniazid
La pharmacogénétique.